Literature DB >> 28569238

Analyzing breath samples of hypoglycemic events in type 1 diabetes patients: towards developing an alternative to diabetes alert dogs.

Amanda P Siegel1, Ali Daneshkhah, Dana S Hardin, Sudhir Shrestha, Kody Varahramyan, Mangilal Agarwal.   

Abstract

Diabetes is a disease that involves dysregulation of metabolic processes. Patients with type 1 diabetes (T1D) require insulin injections and measured food intake to maintain clinical stability, manually tracking their results by measuring blood glucose levels. Low blood glucose levels, hypoglycemia, can be extremely dangerous and can result in seizures, coma, or even death. Canines trained as diabetes alert dogs (DADs) have demonstrated the ability to detect hypoglycemia from breath, which led us to hypothesize that hypoglycemia, a metabolic dysregulation leading to low blood glucose levels, could be identified through analyzing volatile organic compounds (VOCs) contained within breath. We hoped to replicate the canines' detection ability and success by analytically using gas chromatography/mass spectrometry of VOCs in 128 breath samples collected from 52 youths with T1D at two different diabetes camps. We used different tests for significance including Ranksum, Student's T-test, and difference between means, and found a subset of 56 traces of potential metabolites. Principle component and linear discriminant analysis (LDA) confirmed a hypoglycemic signature likely resides within this group. Supervised machine learning combined with LDA narrowed the list of likely components to seven. The technique of leave one out cross validation demonstrated the model thus developed has a sensitivity of 91% (95% confidence interval (CI) [57.1, 94.7]) and a specificity of 84% (95% CI [73.0, 92.7]) at identifying hypoglycemia. Confidence intervals were obtained by bootstrapping. These results demonstrate that it is possible to differentiate breath samples obtained during hypoglycemic events from all other breath samples by analytical means and could lead to developing a simple analytical monitoring device as an alternative to using DADs.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28569238     DOI: 10.1088/1752-7163/aa6ac6

Source DB:  PubMed          Journal:  J Breath Res        ISSN: 1752-7155            Impact factor:   3.262


  11 in total

Review 1.  Noninvasive glucose detection in exhaled breath condensate.

Authors:  Divya Tankasala; Jacqueline C Linnes
Journal:  Transl Res       Date:  2019-05-30       Impact factor: 7.012

2.  Chemometric Analysis of Urinary Volatile Organic Compounds to Monitor the Efficacy of Pitavastatin Treatments on Mammary Tumor Progression over Time.

Authors:  Paul Grocki; Mark Woollam; Luqi Wang; Shengzhi Liu; Maitri Kalra; Amanda P Siegel; Bai-Yan Li; Hiroki Yokota; Mangilal Agarwal
Journal:  Molecules       Date:  2022-07-03       Impact factor: 4.927

3.  Detection of Volatile Organic Compounds (VOCs) in Urine via Gas Chromatography-Mass Spectrometry QTOF to Differentiate Between Localized and Metastatic Models of Breast Cancer.

Authors:  Mark Woollam; Meghana Teli; Paula Angarita-Rivera; Shengzhi Liu; Amanda P Siegel; Hiroki Yokota; Mangilal Agarwal
Journal:  Sci Rep       Date:  2019-02-21       Impact factor: 4.379

Review 4.  Machine Learning Techniques for Hypoglycemia Prediction: Trends and Challenges.

Authors:  Omer Mujahid; Ivan Contreras; Josep Vehi
Journal:  Sensors (Basel)       Date:  2021-01-14       Impact factor: 3.576

5.  Dog Owners' Survey reveals Medical Alert Dogs can alert to multiple conditions and multiple people.

Authors:  Catherine Reeve; Clara Wilson; Donncha Hanna; Simon Gadbois
Journal:  PLoS One       Date:  2021-04-14       Impact factor: 3.240

6.  Pitavastatin slows tumor progression and alters urine-derived volatile organic compounds through the mevalonate pathway.

Authors:  Luqi Wang; Yue Wang; Andy Chen; Meghana Teli; Rika Kondo; Aydin Jalali; Yao Fan; Shengzhi Liu; Xinyu Zhao; Amanda Siegel; Kazumasa Minami; Mangilal Agarwal; Bai-Yan Li; Hiroki Yokota
Journal:  FASEB J       Date:  2019-10-04       Impact factor: 5.834

Review 7.  A systematic review of the applications of artificial intelligence and machine learning in autoimmune diseases.

Authors:  I S Stafford; M Kellermann; E Mossotto; R M Beattie; B D MacArthur; S Ennis
Journal:  NPJ Digit Med       Date:  2020-03-09

Review 8.  Pathophysiology and aetiology of hypoglycaemic crises.

Authors:  R K Morgan; Y Cortes; L Murphy
Journal:  J Small Anim Pract       Date:  2018-08-13       Impact factor: 1.522

9.  Modeling the Research Landscapes of Artificial Intelligence Applications in Diabetes (GAPRESEARCH).

Authors:  Giang Thu Vu; Bach Xuan Tran; Roger S McIntyre; Hai Quang Pham; Hai Thanh Phan; Giang Hai Ha; Kenneth K Gwee; Carl A Latkin; Roger C M Ho; Cyrus S H Ho
Journal:  Int J Environ Res Public Health       Date:  2020-03-17       Impact factor: 3.390

10.  Non-Invasive Assessment of Metabolic Adaptation in Paediatric Patients Suffering from Type 1 Diabetes Mellitus.

Authors:  Phillip Trefz; Sibylle C Schmidt; Pritam Sukul; Jochen K Schubert; Wolfram Miekisch; Dagmar-Christiane Fischer
Journal:  J Clin Med       Date:  2019-10-26       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.